Ampleia is a venture-building organization focused on supporting projects in rare disease therapeutics. They collaborate with scientists and entrepreneurs to develop therapeutic options for underserved indications.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Ampleia is a venture studio founded in 2023 and based in Paris, France. It is dedicated to developing therapies for rare diseases by leveraging a vast network of over 6,000 medical and scientific experts. The organization aims to create companies that not only provide significant clinical benefits but also yield high financial returns, capitalizing on the unique economics of rare diseases.
Ampleia invests in the development of therapies for rare diseases, emphasizing high pricing per patient and a greater likelihood of success in clinical trials for orphan drugs. The organization believes that the economics of rare diseases are fundamentally different, leading to potentially significant returns on investment.
Ampleia offers a unique venture-building approach, combining scientific sourcing with execution-focused teams to advance programs from research into preclinical and clinical development. The organization provides access to a vast network of experts and resources within the AFM-Téléthon ecosystem.
Ampleia focuses on therapies for rare diseases.
Ampleia provides access to a network of experts and resources to help advance therapeutic programs.
Organizations that do similar work to Ampleia.
Venture studioCambrian Ventures LLP is a venture builder and investor focused on deep-tech innovations in healthcare, biotech, foodtech, and digital assets. Based in Singapore, it partners with startups to accelerate their growth and address healthcare challenges.
Venture studioHealthTech180 is a European venture studio focused on bridging academic research and commercial markets in healthcare. They partner with universities to advance early-stage healthtech companies addressing high unmet medical needs.
Venture studioViva BioInnovator is a venture studio based in Shanghai, China, focused on the creation and development of early-stage biotech startups. It provides investment and incubation support to facilitate the development of novel therapeutics.
Venture studioBoCG Ventures is a boutique advisory and investment firm operating in California and the UAE, focusing on technology-enabled ventures through its proprietary Venture Operating Model (VOM). The firm emphasizes antifragility and operational excellence to drive scalable growth.
Superscout Pro
Is this page right?Reviewed · How the research works